Biomarkers: Released On 27 January 2015

BIOMARKERS
Released On 27th January 2015
Biomarkers Market research report focuses on the different types of biomarkers and their
impact on various disease areas such as oncology (prostate, ovarian, breast and lung),
neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart
disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract
infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative
stress, liver disease, pulmonary disease and aging, etc. The study provides Global
Biomarkers market size by the above disease areas and also by prominent biomarker
identification technologies including imaging, genomics, proteomics, metabolomics, gene
expression and other technologies comprising fluorescent indicators, lab-on-chip, nuclear
magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology.
Compilation of Worldwide Patents and Research related to Biomarkers is also provided.
Biomarkers Market offers market values for global geographic regions including North
America, Europe, Asia-Pacific and Rest of World.
Browse complete Report on:
http://www.jsbmarketresearch.com/healthcare-medical/r-biomarkers-68420
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/
Table of Contents
1. SCOPE AND METHODOLOGY
2. REPORT SYNOPSIS
2.1 Introduction
2.2 Segmentation of Biomarkers
Exhibit 1. Segmentation of Global Biomarkers Market by Therapeutic Area and
Identification Technology
Identification Technologies
Imaging
Genomics
Proteomics
Metabolomics
Gene Expression
Therapeutic Areas
Oncology
Cardiology
Neurology
Infectious Diseases
Exhibit 2. Segmentation by Therapeutic Area for Oncology, Cardiology, Neurology, and
Infectious Diseases
2.3 Global Biomarkers Market
Exhibit 3. Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$
Billion (Graphical Representation Included)
Exhibit 4. List of Global Major Biomarkers Companies
3. MARKET DYNAMICS
3.1 Global Market Overview
3.2 Global Biomarkers Market
Exhibit 5. Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$
Million for North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation Included)
Exhibit 6. Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America,
Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.3 North American Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 7. Biomarkers - North American Market Estimations & Predictions (2005 -2020)
in US$ Million for United States and Canada (Graphical Representation Included)
Exhibit 8. Biomarkers - North American Market Shares (2010, 2015 & 2020) for United
States and Canada (Graphical Representation Included)
3.3 (I) United States Biomarkers Market
3.3 (II) Canadian Biomarkers Market
Exhibit 9. List of North American Biomarkers Companies
3.4 European Biomarkers Market
Exhibit 10. Biomarkers - European Market Estimations and Predictions (2005-2020) in
US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden,
Russia and Rest of Europe (Graphical Representation Included)
Exhibit 11. Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK,
Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical
3.4 (I) German Biomarkers Market
3.4 (II) United Kingdom Biomarkers Market
3.4 (III) Italian Biomarkers Market
3.4 (IV) French Biomarkers Market
3.4 (V) Spanish Biomarkers Market
3.4 (VI) Swiss Biomarkers Market
3.4 (VII) Belgian Biomarkers Market
3.4 (VIII) Swedish Biomarkers Market
3.4 (IX) Russian Biomarkers Market
Exhibit 12. List of European Biomarkers Companies
3.5 Asia-Pacific Biomarkers Market
Exhibit 13. Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in
US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical
Exhibit 14. Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan,
China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)
3.5 (I) Japanese Biomarkers Market
3.5 (II) Chinese Biomarkers Market
3.5 (III) Indian Biomarkers Market
3.5 (IV) Australian Biomarkers Market
3.5 (V) South Korean Biomarkers Market
Exhibit 15. List of Asia-Pacific Biomarkers Companies

Tel No- 91 2241236650 / +91 - 998 729 5242
3.6 Rest of World Biomarkers Market

Exhibit 16. Biomarkers - Rest of World Market Estimations and Predictions (2005-2020)
for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical
Exhibit 17. Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel,
South Africa, Brazil and Other Countries (Graphical Representation Included)
3.6 (I) Israeli Biomarkers Market
3.6 (II) South African Biomarkers Market
3.6 (III) Brazilian Biomarkers Market
Exhibit 18. List of Rest of World Biomarkers Companies
3.7 Market Trends
What are Pharma Companies Looking For in Biomarkers?
Biomarkers - An Emerging Trend in Pharma Industry
Innovative Biomarker Discovery Methods Aid in Drug Development Stages
Biomarkers Becoming Important in Developing Better Drugs
Pharma Companies Investing Huge Amounts in Biomarkers Discovery
3.8 Company Profiles - Major Players in Biomarker Market
Abbott Diagnostics (USA)
Affymetrix, Inc. (USA)
Agendia BV ((The Netherlands))
Agilent Technologies, Inc. (USA)
AltheaDx, Inc. (USA)
More.
3.9 Major Activities in Biomarker Industry
Exonhit and Pfizer Enters into Research Agreement for AD Biomarkers Identification
IVD Acquisition Corporation Takes Over Immucor
TcLand Expression Strategic Partnership for Development of Novel RA Biomarkers
Stemina Biomarker and Pioneer Hi-Bred Sign Research Agreement
Astellas Pharma Completes Acquisition of OSI Pharmaceuticals
OriGene and ISB alliance for SRM/MRM database
Duke Associates with LabCorp to Develop a Joint Venture Company, the Biomarker
Factory
Thermo Fisher Enters into a Collaboration Agreement with LCP for Improved Biomarker
Discovery and Assay Development Process
Axela Associates with Salomao & Zoppi and CRIA Opportunities

Tel No- 91 2241236650 / +91 - 998 729 5242
SQI Diagnostics Enters into a Development Deal with Silliker for Marketing of Botulism
Toxin Panel
PROOF Centre Enters into Partnership Agreement with Luminex
Celerion Completes Acquisition of MDS Pharma Services Early Stage Clinical
Development Operations
Philips Signs a MoU with Definiens for Co-Developing and Marketing Solutions for
Digital Pathology
Ricerca Biosciences LLC Purchases MDS Pharma Services
PAREXEL International and Proteome Sciences Forms an Alliance for Biomarker
Development
Biocartis Acquires Automated DNA/RNA Molecular Diagnostic Testing Platform of
Philips
More.
3.10 Major Product Innovations/Launches in Biomarker Industry
AB SCIEX Expands Eksigent Chip Column Family for Nano and Micro LC Proteomics
Analysis
WaferGen Biosystems Supplies SmartChip Real-Time PCR System to Kyoto University
for Enhancing the Research on Regenerative Tissue
C-Path Becomes First Ever Biomarker Panel to be Approved by Japanese Regulators
Tethys Inc., Receives US Patent for the Outstanding PreDx Diabetes Risk Score Test
Millipore Launches Test Kits for Human Kidney Damage
TGen Piloted Group Led Studies Identify Genetic Links to Kidney Disease
WaferGen Biosystems Inc., Markets Two of Gene Expression Profiling Panels Designed
for SmartChip Real-Time PCR System
Cancer Prevention and Research Institute of Texas Awards Funds to Rules-Based
Medicine
Quintiles Launches Wide-Ranging Suite of PI3K Biomarker Assays
BioMarker Strategies Obtains Funds of US$1 Million from NCI
StemTroniX and Power3 Submit Patent Application for Stem Cell Protein Biomarkers
Pronota Achieves Base of Next Generation Sequencing Application for Identification and
Quantification of Proteins
bioMrieux and GlaxoSmithKline Enter into Alliance for the Development of Molecular
Theranostic Test
More..
3.11 Therapeutic Area Analysis

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 19. Biomarkers by Therapeutic Area - Global Market Estimations and Predictions
(2005-2020) in US$ Million for Oncology, Cardiology, Neurology, Infectious Disease,
Genetic Disorders & Other (Graphical Representation Included)
Exhibit 20. Biomarkers - Global Market Shares (2010, 2015 & 2020) for Oncology,
Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical
3.11.1 ONCOLOGY
3.11.1.1 Global Oncology Biomarkers Market
Exhibit 21. Biomarkers in Oncology - Global Market Estimations and Predictions (20052020) in US$ Million for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer
and Other (Graphical Representation Included)
Exhibit 22. Biomarkers in Oncology - Global Market Shares (2010, 2015 & 2020) for
Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical
Exhibit 23. Biomarkers in Oncology - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World
(Graphical Representation Included)
Exhibit 24. Biomarkers in Oncology - Global Market Shares (2010, 2015 & 2020) for
North America, Europe, Asia-Pacific and Rest of World (Graphical Representation
Included)
3.11.1.2 North American Oncology Biomarkers Market
Exhibit 25. Biomarkers in Oncology - North American Market Estimations and
Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation
Included)
Exhibit 26. Biomarkers in Oncology - North American Market Shares (2010, 2015 &
2020) for USA and Canada (Graphical Representation Included)
3.11.1.2 (I) United States Oncology Biomarkers Market
3.11.1.2 (II) Canadian Oncology Biomarkers Market
Exhibit 27. List of North American Oncology Biomarkers Companies
3.11.1.3 European Oncology Biomarkers Market
Exhibit 28. Biomarkers in Oncology - European Market Estimations and Predictions
(2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium,
Sweden, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 29. Biomarkers in Oncology - European Market Shares (2010, 2015 & 2020) for
Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of
Europe (Graphical Representation Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.1.3 (I) German Oncology Biomarkers Market

3.11.1.3 (II) United Kingdom Oncology Biomarkers Market
3.11.1.3 (III) Italian Oncology Biomarkers Market
3.11.1.3 (IV) French Oncology Biomarkers Market
3.11.1.3 (V) Spanish Oncology Biomarkers Market
3.11.1.3 (VI) Swiss Oncology Biomarkers Market
3.11.1.3 (VII) Belgian Oncology Biomarkers Market
3.11.1.3 (VIII) Swedish Oncology Biomarkers Market
3.11.1.3 (IX) Russian Oncology Biomarkers Market
Exhibit 30. List of European Oncology Biomarkers Companies
3.11.1.4 Asia-Pacific Oncology Biomarkers Market
Exhibit 31. Biomarkers in Oncology - Asia-Pacific Market Estimations and Predictions
(2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included)
Exhibit 32. Biomarkers in Oncology Asia-Pacific Market Shares (2010, 2015 & 2020)
for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation
Included)
3.11.1.4 (I) Japanese Oncology Biomarkers Market
3.11.1.4 (II) Chinese Oncology Biomarkers Market
3.11.1.4 (III) Indian Oncology Biomarkers Market
3.11.1.4 (IV) Australian Oncology Biomarkers Market
3.11.1.4 (V) South Korean Oncology Biomarkers Market
Exhibit 33. List of Asia-Pacific Oncology Biomarkers Companies
3.11.1.5 Rest of World Oncology Biomarkers Market
Exhibit 34. Biomarkers in Oncology - Rest of World Market Estimations and Predictions
(2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical
Exhibit 35. Biomarkers in Oncology - Rest of World Market Shares (2010, 2015 & 2020)
for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.1.5 (I) Israeli Oncology Biomarkers Market
3.11.1.5 (II) South African Oncology Biomarkers Market
3.11.1.5 (III) Brazilian Oncology Biomarkers Market
Exhibit 36. List of Rest of World Oncology Biomarkers Companies
3.11.1.A PROSTATE CANCER
3.11.1.A .1 Global Prostate Cancer Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 37. Prostate Cancer Biomarkers - Global Market Estimations and Predictions
(2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World
Exhibit 38. Prostate Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.1.A .2 North American Prostate Cancer Biomarkers Market
Exhibit 39. Prostate Cancer Biomarkers North American Market Estimations and
Included)
Exhibit 40. Prostate Cancer Biomarkers - North American Market Shares (2010, 2015 &
3.11.1.A .2 (I) United States Prostate Cancer Biomarkers Market
3.11.1.A .2 (II) Canadian Prostate Cancer Biomarkers Market
Exhibit 41. List of North American Prostate Cancer Biomarkers Companies
3.11.1.A .3 European Prostate Cancer Biomarkers Market
Exhibit 42. Prostate Cancer Biomarkers European Market Estimations and Predictions
Exhibit 43. Prostate Cancer Biomarkers - European Market Shares (2010, 2015 & 2020)
for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of
Europe(Graphical Representation Included)
3.11.1.A .3 (I) German Prostate Cancer Biomarkers Market
3.11.1.A .3 (II) United Kingdom Prostate Cancer Biomarkers Market
3.11.1.A .3 (III) Italian Prostate Cancer Biomarkers Market
3.11.1.A .3 (IV) French Prostate Cancer Biomarkers Market
3.11.1.A .3 (V) Spanish Prostate Cancer Biomarkers Market
3.11.1.A .3 (VI) Swiss Prostate Cancer Biomarkers Market
3.11.1.A .3 (VII) Belgian Prostate Cancer Biomarkers Market
3.11.1.A .3 (VIII) Swedish Prostate Cancer Biomarkers Market
3.11.1.A .3 (IX) Russian Prostate Cancer Biomarkers Market
Exhibit 44. List of European Prostate Cancer Biomarkers Companies
3.11.1.A .4 Asia-Pacific Prostate Cancer Biomarkers Market
Exhibit 45. Prostate Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 46. Prostate Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 &
2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical
3.11.1.A .4 (I) Japanese Prostate Cancer Biomarkers Market
3.11.1.A .4 (II) Chinese Prostate Cancer Biomarkers Market
3.11.1.A .4 (III) Indian Prostate Cancer Biomarkers Market
3.11.1.A .4 (IV) Australian Prostate Cancer Biomarkers Market
3.11.1.A .4 (V) South Korean Prostate Cancer Biomarkers Market
Exhibit 47. List of Asia-Pacific Prostate Cancer Biomarkers Companies
3.11.1.A .5 Rest of World Prostate Cancer Biomarkers Market
Exhibit 48. Prostate Cancer Biomarkers - Rest of World Market Estimations and
Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$
Million (Graphical Representation Included)
Exhibit 49. Prostate Cancer Biomarkers - Rest of World Market Shares (2010, 2015 &
2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation
Included)
3.11.1.A .5 (I) Israeli Prostate Cancer Biomarkers Market
3.11.1.A .5 (II) South African Prostate Cancer Biomarkers Market
3.11.1.A .5 (III) Brazilian Prostate Cancer Biomarkers Market
3.11.1. B OVARIAN CANCER
3.11.1.B .1 Global Ovarian Cancer Biomarkers Market
Exhibit 50. Ovarian Cancer Biomarkers - Global Market Estimations and Predictions
Exhibit 51. Ovarian Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.1. B .2 North American Ovarian Cancer Biomarkers Market
Exhibit 52. Ovarian Cancer Biomarkers North American Market Estimations and
Included)
Exhibit 53. Ovarian Cancer Biomarkers - North American Market Shares (2010, 2015 &
2020) for USA and Canada
3.11.1. B .2 (I) United States Ovarian Cancer Biomarkers Market
3.11.1. B .2 (II) Canadian Ovarian Cancer Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 54. List of North American Ovarian Cancer Biomarkers Companies

3.11.1. B .3 European Ovarian Cancer Biomarkers Market
Exhibit 55. Ovarian Cancer Biomarkers European Market Estimations and Predictions
Exhibit 56. Ovarian Cancer Biomarkers - European Market Shares (2010, 2015 & 2020)
3.11.1. B .3 (I) German Ovarian Cancer Biomarkers Market
3.11.1. B .3 (II) United Kingdom Ovarian Cancer Biomarkers Market
3.11.1. B .3 (III) Italian Ovarian Cancer Biomarkers Market
3.11.1. B .3 (IV) French Ovarian Cancer Biomarkers Market
3.11.1. B .3 (V) Spanish Ovarian Cancer Biomarkers Market
3.11.1. B .3 (VI) Swiss Ovarian Cancer Biomarkers Market
3.11.1. B .3 (VII) Belgian Ovarian Cancer Biomarkers Market
3.11.1. B .3 (VIII) Swedish Ovarian Cancer Biomarkers Market
3.11.1. B .3 (IX) Russian Ovarian Cancer Biomarkers Market
Exhibit 57. List of European Ovarian Cancer Biomarkers Companies
3.11.1. B .4 Asia-Pacific Ovarian Cancer Biomarkers Market
Exhibit 58. Ovarian Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions
Exhibit 59. Ovarian Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 &
2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical
3.11.1. B .4 (I) Japanese Ovarian Cancer Biomarkers Market
3.11.1. B .4 (II) Chinese Ovarian Cancer Biomarkers Market
3.11.1. B .4 (III) Indian Ovarian Cancer Biomarkers Market
3.11.1. B .4 (IV) Australian Ovarian Cancer Biomarkers Market
3.11.1. B .4 (V) South Korean Ovarian Cancer Biomarkers Market
Exhibit 60. List of Asia-Pacific Ovarian Cancer Biomarkers Companies
3.11.1. B .5 Rest of World Ovarian Cancer Biomarkers Market
Exhibit 61. Ovarian Cancer Biomarkers - Rest of World Market Estimations and

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 62. Ovarian Cancer Biomarkers - Rest of World Market Shares (2010, 2015 &
2020) for Israel, South Africa, Brazil
and Other Countries (Graphical Representation Included)
3.11.1. B .5 (I) Israeli Ovarian Cancer Biomarkers Market
3.11.1. B .5 (II) South African Ovarian Cancer Biomarkers Market
3.11.1. B .5 (III) Brazilian Ovarian Cancer Biomarkers Market
Exhibit 63. List of Rest of World Ovarian Cancer Biomarkers Companies
3.11.1. C BREAST CANCER
3.11.1. C.1 Global Breast Cancer Biomarkers Market
Exhibit 64. Breast Cancer Biomarkers - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World
Exhibit 65. Breast Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.1. C.2 North American Breast Cancer Biomarkers Market
Exhibit 66. Breast Cancer Biomarkers North American Market Estimations and
Included)
Exhibit 67. Breast Cancer Biomarkers - North American Market Shares (2010, 2015 &
3.11.1. C.2 (I) United States Breast Cancer Biomarkers Market
3.11.1. C.2 (II) Canadian Breast Cancer Biomarkers Market
Exhibit 68. List of North American Breast Cancer Biomarkers Companies
3.11.1. C.3 European Breast Cancer Biomarkers Market
Exhibit 69. Breast Cancer Biomarkers European Market Estimations and Predictions
Exhibit 70. Breast Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for
3.11.1. C.3 (I) German Breast Cancer Biomarkers Market
3.11.1. C.3 (II) United Kingdom Breast Cancer Biomarkers Market
3.11.1. C.3 (III) Italian Breast Cancer Biomarkers Market
3.11.1. C.3 (IV) French Breast Cancer Biomarkers Market
3.11.1. C.3 (V) Spanish Breast Cancer Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.1. C.3 (VI) Swiss Breast Cancer Biomarkers Market

3.11.1. C.3 (VII) Belgian Breast Cancer Biomarkers Market
3.11.1. C.3 (VIII) Swedish Breast Cancer Biomarkers Market
3.11.1. C.3 (IX) Russian Breast Cancer Biomarkers Market
Exhibit 71. List of European Breast Cancer Biomarkers Companies
3.11.1. C.4 Asia-Pacific Breast Cancer Biomarkers Market
Exhibit 72. Breast Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions
Exhibit 73. Breast Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.1. C.4 (I) Japanese Breast Cancer Biomarkers Market
3.11.1. C.4 (II) Chinese Breast Cancer Biomarkers Market
3.11.1. C.4 (III) Indian Breast Cancer Biomarkers Market
3.11.1. C.4 (IV) Australian Breast Cancer Biomarkers Market
3.11.1. C.4 (V) South Korean Breast Cancer Biomarkers Market
Exhibit 74. List of Asia-Pacific Breast Cancer Biomarkers Companies
3.11.1. C.5 Rest of World Breast Cancer Biomarkers Market
Exhibit 75. Breast Cancer Biomarkers - Rest of World Market Estimations and Predictions
Exhibit 76. Breast Cancer Biomarkers - Rest of World Market Shares (2010, 2015 &
Included)
3.11.1. C.5 (I) Israeli Breast Cancer Biomarkers Market
3.11.1. C.5 (II) South African Breast Cancer Biomarkers Market
3.11.1. C.5 (III) Brazilian Breast Cancer Biomarkers Market
Exhibit 77. List of Rest of World Breast Cancer Biomarkers Companies
3.11.1. D LUNG CANCER
3.11.1. D.1 Global Lung Cancer Biomarkers Market
Exhibit 78. Lung Cancer Biomarkers - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 79. Lung Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.1. D.2 North American Lung Cancer Biomarkers Market
Exhibit 80. Lung Cancer Biomarkers North American Market Estimations and
Included)
Exhibit 81. Lung Cancer Biomarkers - North American Market Shares (2010, 2015 &
3.11.1. D.2 (I) United States Lung Cancer Biomarkers Market
3.11.1. D.2 (II) Canadian Lung Cancer Biomarkers Market
Exhibit 82. List of North American Lung Cancer Biomarkers Companies
3.11.1. D.3 European Lung Cancer Biomarkers Market
Exhibit 83. Lung Cancer Biomarkers European Market Estimations and Predictions
Exhibit 84. Lung Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for
3.11.1. D.3 (I) German Lung Cancer Biomarkers Market
3.11.1. D.3 (II) United Kingdom Lung Cancer Biomarkers Market
3.11.1. D.3 (III) Italian Lung Cancer Biomarkers Market
3.11.1. D.3 (IV) French Lung Cancer Biomarkers Market
3.11.1. D.3 (V) Spanish Lung Cancer Biomarkers Market
3.11.1. D.3 (VI) Swiss Lung Cancer Biomarkers Market
3.11.1. D.3 (VII) Belgian Lung Cancer Biomarkers Market
3.11.1. D.3 (VIII) Swedish Lung Cancer Biomarkers Market
3.11.1. D.3 (IX) Russian Lung Cancer Biomarkers Market
Exhibit 85. List of European Lung Cancer Biomarkers Companies
3.11.1. D.4 Asia-Pacific Lung Cancer Biomarkers Market
Exhibit 86. Lung Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions
Exhibit 87. Lung Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.1. D.4 (I) Japanese Lung Cancer Biomarkers Market

3.11.1. D.4 (II) Chinese Lung Cancer Biomarkers Market
3.11.1. D.4 (III) Indian Lung Cancer Biomarkers Market
3.11.1. D.4 (IV) Australian Lung Cancer Biomarkers Market
3.11.1. D.4 (V) South Korean Lung Cancer Biomarkers Market
Exhibit 88. List of Asia-Pacific Lung Cancer Biomarkers Companies
3.11.1. D.5 Rest of World Lung Cancer Biomarkers Market
Exhibit 89. Lung Cancer Biomarkers - Rest of World Market Estimations and Predictions
Exhibit 90. Lung Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020)
for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.1. D.5 (I) Israeli Lung Cancer Biomarkers Market
3.11.1. D.5 (II) South African Lung Cancer Biomarkers Market
3.11.1. D.5 (III) Brazilian Lung Cancer Biomarkers Market
Exhibit 91. List of Rest of World Lung Cancer Biomarkers Companies
3.11.1. E OTHER CANCERS
3.11.1. E.1 Global Other Cancer Biomarkers Market
Exhibit 92. Other Cancer Biomarkers - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World
Exhibit 93. Other Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.1. E.2 North American Other Cancers Biomarkers Market
Exhibit 94. Other Cancers Biomarkers North American Market Estimations and
Included)
Exhibit 95. Other Cancers Biomarkers - North American Market Shares (2010, 2015 &
Exhibit 96. List of North American Other Cancers Biomarkers Companies
3.11.1. E.3 European Other Cancers Biomarkers Market
Exhibit 97. Other Cancers Biomarkers European Market Estimations and Predictions

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 98. Other Cancers Biomarkers - European Market Shares (2010, 2015 & 2020) for
3.11.1. E.4 Asia-Pacific Other Cancers Biomarkers Market
Exhibit 99. Other Cancers Biomarkers - Asia-Pacific Market Estimations and Predictions
Exhibit 100. Other Cancers Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.1. E.5 Rest of World Other Cancers Biomarkers Market
Exhibit 101. Other Cancers Biomarkers - Rest of World Market Estimations and
Exhibit 102. Other Cancers Biomarkers - Rest of World Market Shares (2010, 2015 &
Included)
3.11.2 CARDIOLOGY
3.11.2.1 Global Cardiology Biomarkers Market
Exhibit 103. Biomarkers in Cardiology - Global Market Estimations and Predictions
(2005-2020) in US$ Million for Coronary Heart Disease, Heart Failure, Myocardial
Infarction and Other (Graphical Representation Included)
Exhibit 104. Biomarkers in Cardiology - Global Market Shares (2010, 2015 & 2020) for
Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical
Exhibit 105. Biomarkers in Cardiology - Global Market Estimations and Predictions
Exhibit 106. Biomarkers in Cardiology - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.2.2 North American Cardiology Biomarkers Market
Exhibit 107. Biomarkers in Cardiology - North American Market Estimations and
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 108. Biomarkers in Cardiology - North American Market Shares (2010, 2015 &
3.11.2.2 (I) United States Cardiology Biomarkers Market
3.11.2.2 (II)Canadian Cardiology Biomarkers Market
Exhibit 109. List of North American Cardiology Biomarkers Companies
3.11.2.3 European Cardiology Biomarkers Market
Exhibit 110. Biomarkers in Cardiology - European Market Estimations and Predictions
Exhibit 111. Biomarkers in Cardiology - European Market Shares (2010, 2015 & 2020)
3.11.2.3 (I) German Cardiology Biomarkers Market
3.11.2.3 (II) United Kingdom Cardiology Biomarkers Market
3.11.2.3 (III) Italian Cardiology Biomarkers Market
3.11.2.3 (IV) French Cardiology Biomarkers Market
3.11.2.3 (V) Spanish Cardiology Biomarkers Market
3.11.2.3 (VI) Swiss Cardiology Biomarkers Market
3.11.2.3 (VII) Belgian Cardiology Biomarkers Market
3.11.2.3 (VIII) Swedish Cardiology Biomarkers Market
3.11.2.3 (IX) Russian Cardiology Biomarkers Market
List Of Tables
Exhibit 112. List of European Cardiology Biomarkers Companies
3.11.2.4 Asia-Pacific Cardiology Biomarkers Market
Exhibit 113. Biomarkers in Cardiology - Asia-Pacific Market Estimations and Predictions
Exhibit 114. Biomarkers in Cardiology Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.2.4 (I) Japanese Cardiology Biomarkers Market
3.11.2.4 (II) Chinese Cardiology Biomarkers Market
3.11.2.4 (III) Indian Cardiology Biomarkers Market
3.11.2.4 (IV) Australian Cardiology Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.2.4 (V) South Korean Cardiology Biomarkers Market

Exhibit 115. List of Asia-Pacific Cardiology Biomarkers Companies
3.11.2.5 Rest of World Cardiology Biomarkers Market
Exhibit 116. Biomarkers in Cardiology - Rest of World Market Estimations and
Exhibit 117. Biomarkers in Cardiology - Rest of World Market Shares (2010, 2015 &
Included)
3.11.2.5 (I) Israeli Cardiology Biomarkers Market
3.11.2.5 (II) South African Cardiology Biomarkers Market
3.11.2.5 (III) Brazilian Cardiology Biomarkers Market
Exhibit 118. List of Rest of World Cardiology Biomarkers Companies
3.11.2.A CORONARY HEART DISEASE
3.11.2.A.1 Global Coronary Heart Disease Biomarkers Market
Exhibit 119. Coronary Heart Disease Biomarkers - Global Market Estimations and
Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest
of World (Graphical Representation Included)
Exhibit 120. Coronary Heart Disease Biomarkers - Global Market Shares (2010, 2015 &
2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical
3.11.2.A.2 North American Coronary Heart Disease Biomarkers Market
Exhibit 121. Coronary Heart Disease Biomarkers North American Market Estimations
and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical
Exhibit 122. Coronary Heart Disease Biomarkers - North American Market Shares (2010,
2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.2.A.2 (I) United States Coronary Heart Disease Biomarkers Market
3.11.2.A.2 (II) Canadian Coronary Heart Disease Biomarkers Market
Exhibit 123. List of North American Coronary Heart Disease Biomarkers Companies
3.11.2.A.3 European Coronary Heart Disease Biomarkers Market
Exhibit 124. Coronary Heart Disease Biomarkers European Market Estimations and
Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain,
Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 125. Coronary Heart Disease Biomarkers - European Market Shares (2010, 2015
& 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia
and Rest of Europe(Graphical Representation Included)
3.11.2.A.3 (I) German Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (II) United Kingdom Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (III) Italian Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (IV) French Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (V) Spanish Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (VI) Swiss Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (VII) Belgian Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (VIII) Swedish Coronary Heart Disease Biomarkers Market
3.11.2.A.3 (IX) Russian Coronary Heart Disease Biomarkers Market
Exhibit 126. List of European Coronary Heart Disease Biomarkers Companies
3.11.2.A.4 Asia-Pacific Coronary Heart Disease Biomarkers Market
Exhibit 127. Coronary Heart Disease Biomarkers - Asia-Pacific Market Estimations and
Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea
and Asia-Pacific (Graphical Representation Included)
Exhibit 128. Coronary Heart Disease Biomarkers - Asia-Pacific Market Shares (2010,
2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical
3.11.2.A.4 (I) Japanese Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (II) Chinese Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (III) Indian Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (IV) Australian Coronary Heart Disease Biomarkers Market
3.11.2.A.4 (V) South Korean Coronary Heart Disease Biomarkers Market
Exhibit 129. List of Asia-Pacific Coronary Heart Disease Biomarkers Companies
3.11.2.A.5 Rest of World Coronary Heart Disease Biomarkers Market
Exhibit 130. Coronary Heart Disease Biomarkers - Rest of World Market Estimations and
Exhibit 131. Coronary Heart Disease Biomarkers - Rest of World Market Shares (2010,
2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical
3.11.2.A.5 (I) Israeli Coronary Heart Disease Biomarkers Market
3.11.2.A.5 (II) South African Coronary Heart Disease Biomarkers Market
3.11.2.A.5 (III) Brazilian Coronary Heart Disease Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 132. List of Rest of World Coronary Heart Disease Biomarkers Companies
3.11.2.B HEART FAILURE
3.11.2.B.1 Global Heart Failure Biomarkers Market
Exhibit 133. Heart Failure Biomarkers - Global Market Estimations and Predictions
Exhibit 134. Heart Failure Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.2.B.2 North American Heart Failure Biomarkers Market
Exhibit 135. Heart Failure Biomarkers North American Market Estimations and
Predictions (2005-2020) in US$
Million for USA and Canada (Graphical Representation Included)
Exhibit 136. Heart Failure Biomarkers - North American Market Shares (2010, 2015 &
3.11.2.B.2 (I) United States Heart Failure Biomarkers Market
3.11.2.B.2 (II) Canadian Heart Failure Biomarkers Market
Exhibit 137. List of North American Heart Failure Biomarkers Companies
3.11.2.B.3 European Heart Failure Biomarkers Market
Exhibit 138. Heart Failure Biomarkers European Market Estimations and Predictions
Exhibit 139. Heart Failure Biomarkers - European Market Shares (2010, 2015 & 2020) for
3.11.2.B.3 (I) German Heart Failure Biomarkers Market
3.11.2.B.3 (II) United Kingdom Heart Failure Biomarkers Market
3.11.2.B.3 (III) Italian Heart Failure Biomarkers Market
3.11.2.B.3 (IV) French Heart Failure Biomarkers Market
3.11.2.B.3 (V) Spanish Heart Failure Biomarkers Market
3.11.2.B.3 (VI) Swiss Heart Failure Biomarkers Market
3.11.2.B.3 (VII) Belgian Heart Failure Biomarkers Market
3.11.2.B.3 (VIII) Swedish Heart Failure Biomarkers Market
3.11.2.B.3 (IX) Russian Heart Failure Biomarkers Market
Exhibit 140. List of European Heart Failure Biomarkers Companies
3.11.2.B.4 Asia-Pacific Heart Failure Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 141. Heart Failure Biomarkers - Asia-Pacific Market Estimations and Predictions
Exhibit 142. Heart Failure Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.2.B.4 (I) Japanese Heart Failure Biomarkers Market
3.11.2.B.4 (II) Chinese Heart Failure Biomarkers Market
3.11.2.B.4 (III) Indian Heart Failure Biomarkers Market
3.11.2.B.4 (IV) Australian Heart Failure Biomarkers Market
3.11.2.B.4 (V) South Korean Heart Failure Biomarkers Market
Exhibit 143. List of Asia-Pacific Heart Failure Biomarkers Companies
3.11.2.B.5 Rest of World Heart Failure Biomarkers Market
Exhibit 144. Heart Failure Biomarkers - Rest of World Market Estimations and
Exhibit 145. Heart Failure Biomarkers - Rest of World Market Shares (2010, 2015 &
Included)
3.11.2.B.5 (I) Israeli Heart Failure Biomarkers Market
3.11.2.B.5 (II) South African Heart Failure Biomarkers Market
3.11.2.B.5 (III) Brazilian Heart Failure Biomarkers Market
Exhibit 146. List of Rest of World Heart Failure Biomarkers Companies
3.11.2.C MYOCARDIAL INFARCTION
3.11.2.C.1 Global Myocardial Infarction Biomarkers Market
Exhibit 147. Myocardial Infarction Biomarkers - Global Market Estimations and
Exhibit 148. Myocardial Infarction Biomarkers - Global Market Shares (2010, 2015 &
3.11.2.C.2 North American Myocardial Infarction Biomarkers Market
Exhibit 149. Myocardial Infarction Biomarkers North American Market Estimations and
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 150. Myocardial Infarction Biomarkers - North American Market Shares (2010,
3.11.2.C.2 (I) United States Myocardial Infarction Biomarkers Market
3.11.2.C.2 (II) Canadian Myocardial Infarction Biomarkers Market
Exhibit 151. List of North American Myocardial Infarction Biomarkers Companies
3.11.2.C.3 European Myocardial Infarction Biomarkers Market
Exhibit 152. Myocardial Infarction Biomarkers European Market Estimations and
Included)
Exhibit 153. Myocardial Infarction Biomarkers - European Market Shares (2010, 2015 &
2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and
Rest of Europe(Graphical Representation Included)
3.11.2.C.3 (I) German Myocardial Infarction Biomarkers Market
3.11.2.C.3 (II) United Kingdom Myocardial Infarction Biomarkers Market
3.11.2.C.3 (III) Italian Myocardial Infarction Biomarkers Market
3.11.2.C.3 (IV) French Myocardial Infarction Biomarkers Market
3.11.2.C.3 (V) Spanish Myocardial Infarction Biomarkers Market
3.11.2.C.3 (VI) Swiss Myocardial Infarction Biomarkers Market
3.11.2.C.3 (VII) Belgian Myocardial Infarction Biomarkers Market
3.11.2.C.3 (VIII) Swedish Myocardial Infarction Biomarkers Market
3.11.2.C.3 (IX) Russian Myocardial Infarction Biomarkers Market
Exhibit 154. List of European Myocardial Infarction Biomarkers Companies
3.11.2.C.4 Asia-Pacific Myocardial Infarction Biomarkers Market
Exhibit 155. Myocardial Infarction Biomarkers - Asia-Pacific Market Estimations and
Exhibit 156. Myocardial Infarction Biomarkers - Asia-Pacific Market Shares (2010, 2015
& 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical
3.11.2.C.4 (I) Japanese Myocardial Infarction Biomarkers Market
3.11.2.C.4 (II) Chinese Myocardial Infarction Biomarkers Market
3.11.2.C.4 (III) Indian Myocardial Infarction Biomarkers Market
3.11.2.C.4 (IV) Australian Myocardial Infarction Biomarkers Market
3.11.2.C.4 (V) South Korean Myocardial Infarction Biomarkers Market
Exhibit 157. List of Asia-Pacific Myocardial Infarction Biomarkers Companies

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.2.C.5 Rest of World Myocardial Infarction Biomarkers Market

Exhibit 158. Myocardial Infarction Biomarkers - Rest of World Market Estimations and
Exhibit 159. Myocardial Infarction Biomarkers - Rest of World Market Shares (2010,
3.11.2.C.5 (I) Israeli Myocardial Infarction Biomarkers Market
3.11.2.C.5 (II) South African Myocardial Infarction Biomarkers Market
3.11.2.C.5 (III) Brazilian Myocardial Infarction Biomarkers Market
Exhibit 160. List of Rest of World Myocardial Infarction Biomarkers Companies
3.11.2.D OTHER CARDIAC BIOMARKERS
3.11.2.D.1 Global Other Cardiac Biomarkers Market
Exhibit 161. Other Cardiac Biomarkers - Global Market Estimations and Predictions
Exhibit 162. Other Cardiac Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.2.D.2 North American Other Cardiac Biomarkers Market
Exhibit 163. Other Cardiac Biomarkers North American Market Estimations and
Included)
Exhibit 164. Other Cardiac Biomarkers - North American Market Shares (2010, 2015 &
3.11.2.D.3 European Other Cardiac Biomarkers Market
Exhibit 165. Other Cardiac Biomarkers European Market Estimations and Predictions
Exhibit 166. Other Cardiac Biomarkers - European Market Shares (2010, 2015 & 2020)
3.11.2.D.4 Asia-Pacific Other Cardiac Biomarkers Market
Exhibit 167. Other Cardiac Biomarkers - Asia-Pacific Market Estimations and Predictions

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 168. Other Cardiac Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.2.D.5 Rest of World Other Cardiac Biomarkers Market
Exhibit 169. Other Cardiac Biomarkers - Rest of World Market Estimations and
Exhibit 170. Other Cardiac Biomarkers - Rest of World Market Shares (2010, 2015 &
Included)
3.11.3 NEUROLOGY
3.11.3.1 Global Neurology Biomarkers Market
Exhibit 171. Biomarkers in Neurology- Global Market Estimations and Predictions (20052020) in US$ Million or Stroke, Brain Tumor, Neurodegenerative Disorders and Other
Exhibit 172. Biomarkers in Neurology- Global Market Shares (2010, 2015 & 2020) for
Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation
Included)
Exhibit 173. Biomarkers in Neurology - Global Market Estimations and Predictions
Exhibit 174. Biomarkers in Neurology - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.3.2 North American Neurology Biomarkers Market
Exhibit 175. Biomarkers in Neurology - North American Market Estimations and
Included)
Exhibit 176. Biomarkers in Neurology - North American Market Shares (2010, 2015 &
3.11.3.2 (I) United States Neurology Biomarkers Market
3.11.3.2 (II) Canadian Neurology Biomarkers Market
Exhibit 177. List of North American Neurology Biomarkers Companies
3.11.3.3 European Neurology Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 178. Biomarkers in Neurology - European Market Estimations and Predictions

Exhibit 179. Biomarkers in Neurology - European Market Shares (2010, 2015 & 2020) for
3.11.3.3 (I) German Neurology Biomarkers Market
3.11.3.3 (II) United Kingdom Neurology Biomarkers Market
3.11.3.3 (III) Italian Neurology Biomarkers Market
3.11.3.3 (IV) French Neurology Biomarkers Market
3.11.3.3 (V) Spanish Neurology Biomarkers Market
3.11.3.3 (VI) Swiss Neurology Biomarkers Market
3.11.3.3 (VII) Belgian Neurology Biomarkers Market
3.11.3.3 (VIII) Swedish Neurology Biomarkers Market
3.11.3.3 (IX) Russian Neurology Biomarkers Market
Exhibit 180. List of European Neurology Biomarkers Companies
3.11.3.4 Asia-Pacific Neurology Biomarkers Market
Exhibit 181. Biomarkers in Neurology - Asia-Pacific Market Estimations and Predictions
Exhibit 182. Biomarkers in Neurology - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.3.4 (I) Japanese Neurology Biomarkers Market
3.11.3. 4 (II) Chinese Neurology Biomarkers Market
3.11.3. 4 (III) Indian Neurology Biomarkers Market
3.11.3. 4 (IV) Australian Neurology Biomarkers Market
3.11.3. 4 (V) South Korean Neurology Biomarkers Market
Exhibit 183. List of Asia-Pacific Neurology Biomarkers Companies
3.11.3.5 Rest of World Neurology Biomarkers Market
Exhibit 184. Biomarkers in Neurology - Rest of World Market Estimations and
Exhibit 185. Biomarkers in Neurology - Rest of World Market Shares (2010, 2015 &
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.3.5 (I) Israeli Neurology Biomarkers Market

3.11.3. 5 (II) South African Neurology Biomarkers Market
3.11.3. 5 (III) Brazilian Neurology Biomarkers Market
Exhibit 186. List of Rest of World Neurology Biomarkers Companies
3.11.3.A STROKE
3.11.3.A.1 Global Stroke Biomarkers Market
Exhibit 187. Stroke Biomarkers - Global Market Estimations and Predictions (2005-2020)
in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical
Exhibit 188. Stroke Biomarkers - Global Market Shares (2010, 2015 & 2020) for North
America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.A.2 North American Stroke Biomarkers Market
Exhibit 189. Stroke Biomarkers North American Market Estimations and Predictions
(2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 190. Stroke Biomarkers - North American Market Shares (2010, 2015 & 2020) for
USA and Canada (Graphical Representation Included)
3.11.3.A.2 (I) United States Stroke Biomarkers Market
3.11.3.A.2 (II) Canadian Stroke Biomarkers Market
Exhibit 191. List of North American Stroke Biomarkers Companies
3.11.3.A.3 European Stroke Biomarkers Market
Exhibit 192. Stroke Biomarkers European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium,
Exhibit 193. Stroke Biomarkers - European Market Shares (2010, 2015 & 2020) for
3.11.3.A.3 (I) German Stroke Biomarkers Market
3.11.3.A.3 (II) United Kingdom Stroke Biomarkers Market
3.11.3.A.3 (III) Italian Stroke Biomarkers Market
3.11.3.A.3 (IV) French Stroke Biomarkers Market
3.11.3.A.3 (V) Spanish Stroke Biomarkers Market
3.11.3.A.3 (VI) Swiss Stroke Biomarkers Market
3.11.3.A.3 (VII) Belgian Stroke Biomarkers Market
3.11.3.A.3 (VIII) Swedish Stroke Biomarkers Market
3.11.3.A.3 (IX) Russian Stroke Biomarkers Market
Exhibit 194. List of European Stroke Biomarkers Companies

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.3.A.4 Asia-Pacific Stroke Biomarkers Market

Exhibit 195. Stroke Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific
Exhibit 196. Stroke Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for
Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation
Included)
3.11.3.A.4 (I) Japanese Stroke Biomarkers Market
3.11.3.A.4 (II) Chinese Stroke Biomarkers Market
3.11.3.A.4 (III) Indian Stroke Biomarkers Market
3.11.3.A.4 (IV) Australian Stroke Biomarkers Market
3.11.3.A.4 (V) South Korean Stroke Biomarkers Market
Exhibit 197. List of Asia-Pacific Stroke Biomarkers Companies
3.11.3.A.5 Rest of World Stroke Biomarkers Market
Exhibit 198. Stroke Biomarkers - Rest of World Market Estimations and Predictions
Exhibit 199. Stroke Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for
Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)
3.11.3.A.5 (I) Israeli Stroke Biomarkers Market
3.11.3.A.5 (II) South African Stroke Biomarkers Market
3.11.3.A.5 (III) Brazilian Stroke Biomarkers Market
Exhibit 200. List of Rest of World Stroke Biomarkers Companies
3.11.3.B BRAIN TUMOR
3.11.3.B.1 Global Brain Tumor Biomarkers Market
Exhibit 201. Brain Tumor Biomarkers - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World
Exhibit 202. Brain Tumor Biomarkers - Global Market Shares (2010, 2015 & 2020) for
Included)
3.11.3.B.2 North American Brain Tumor Biomarkers Market
Exhibit 203. Brain Tumor Biomarkers North American Market Estimations and
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 204. Brain Tumor Biomarkers - North American Market Shares (2010, 2015 &
3.11.3.B.2 (I) United States Brain Tumor Biomarkers Market
3.11.3.B.2 (II) Canadian Brain Tumor Biomarkers Market
Exhibit 205. List of North American Brain Tumor Biomarkers Companies
3.11.3.B.3 European Brain Tumor Biomarkers Market
Exhibit 206. Brain Tumor Biomarkers European Market Estimations and Predictions
Exhibit 207. Brain Tumor Biomarkers - European Market Shares (2010, 2015 & 2020) for
3.11.3.B.3 (I) German Brain Tumor Biomarkers Market
3.11.3.B.3 (II) United Kingdom Brain Tumor Biomarkers Market
3.11.3.B.3 (III) Italian Brain Tumor Biomarkers Market
3.11.3.B.3 (IV) French Brain Tumor Biomarkers Market
3.11.3.B.3 (V) Spanish Brain Tumor Biomarkers Market
3.11.3.B.3 (VI) Swiss Brain Tumor Biomarkers Market
3.11.3.B.3 (VII) Belgian Brain Tumor Biomarkers Market
3.11.3.B.3 (VIII) Swedish Brain Tumor Biomarkers Market
3.11.3.B.3 (IX) Russian Brain Tumor Biomarkers Market
Exhibit 208. List of European Brain Tumor Biomarkers Companies
3.11.3.B.4 Asia-Pacific Brain Tumor Biomarkers Market
Exhibit 209. Brain Tumor Biomarkers - Asia-Pacific Market Estimations and Predictions
Exhibit 210. Brain Tumor Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020)
Included)
3.11.3.B.4 (I) Japanese Brain Tumor Biomarkers Market
3.11.3.B.4 (II) Chinese Brain Tumor Biomarkers Market
3.11.3.B.4 (III) Indian Brain Tumor Biomarkers Market
3.11.3.B.4 (IV) Australian Brain Tumor Biomarkers Market
3.11.3.B.4 (V) South Korean Brain Tumor Biomarkers Market
Exhibit 211. List of Asia-Pacific Brain Tumor Biomarkers Companies
3.11.3.B.5 Rest of World Brain Tumor Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 212. Brain Tumor Biomarkers - Rest of World Market Estimations and Predictions
Exhibit 213. Brain Tumor Biomarkers - Rest of World Market Shares (2010, 2015 &
Included)
3.11.3.B.5 (I) Israeli Brain Tumor Biomarkers Market
3.11.3.B.5 (II) South African Brain Tumor Biomarkers Market
3.11.3.B.5 (III) Brazilian Brain Tumor Biomarkers Market
Exhibit 214. List of Rest of World Brain Tumor Biomarkers Companies
3.11.3.C NEURODEGENERATIVE DISEASES
3.11.3.C.1 Global Neurodegenerative Diseases Biomarkers Market
Exhibit 215. Neurodegenerative Diseases Biomarkers - Global Market Estimations and
Exhibit 216. Neurodegenerative Diseases Biomarkers - Global Market Shares (2010, 2015
& 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical
3.11.3.C.2 North American Neurodegenerative Diseases Biomarkers Market
Exhibit 217. Neurodegenerative Diseases Biomarkers North American Market
Estimations and Predictions (20052020) in US$ Million for USA and Canada (Graphical Representation Included)
Exhibit 218. Neurodegenerative Diseases Biomarkers - North American Market Shares
(2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.3.C.2 (I) United States Neurodegenerative Diseases Biomarkers Market
3.11.3.C.2 (II) Canadian Neurodegenerative Diseases Biomarkers Market
Exhibit 219. List of North American Neurodegenerative Diseases Biomarkers Companies
3.11.3.C.3 European Neurodegenerative Diseases Biomarkers Market
Exhibit 220. Neurodegenerative Diseases Biomarkers European Market Estimations and
Included)
Exhibit 221. Neurodegenerative Diseases Biomarkers - European Market Shares (2010,
2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden,
Russia and Rest of Europe(Graphical Representation Included)
3.11.3.C.3 (I) German Neurodegenerative Diseases Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.3.C.3 (II) United Kingdom Neurodegenerative Diseases Biomarkers Market

3.11.3.C.3 (III) Italian Neurodegenerative Diseases Biomarkers Market
3.11.3.C.3 (IV) French Neurodegenerative Diseases Biomarkers Market
3.11.3.C.3 (V) Spanish Neurodegenerative Diseases Biomarkers Market
3.11.3.C.3 (VI) Swiss Neurodegenerative Diseases Biomarkers Market
3.11.3.C.3 (VII) Belgian Neurodegenerative Diseases Biomarkers Market
3.11.3.C.3 (VIII) Swedish Neurodegenerative Diseases Biomarkers Market
3.11.3.C.3 (IX) Russian Neurodegenerative Diseases Biomarkers Market
Exhibit 222. List of European Neurodegenerative Diseases Biomarkers Companies
3.11.3.C.4 Asia-Pacific Neurodegenerative Diseases Biomarkers Market
Exhibit 223. Neurodegenerative Diseases Biomarkers - Asia-Pacific Market Estimations
and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South
Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 224. Neurodegenerative Diseases Biomarkers - Asia-Pacific Market Shares (2010,
3.11.3.C.4 (I) Japanese Neurodegenerative Diseases Biomarkers Market
3.11.3.C.4 (II) Chinese Neurodegenerative Diseases Biomarkers Market
3.11.3.C.4 (III) Indian Neurodegenerative Diseases Biomarkers Market
3.11.3.C.4 (IV) Australian Neurodegenerative Diseases Biomarkers Market
3.11.3.C.4 (V) South Korean Neurodegenerative Diseases Biomarkers Market
Exhibit 225. List of Asia-Pacific Neurodegenerative Diseases Biomarkers Companies
3.11.3.C.5 Rest of World Neurodegenerative Diseases Biomarkers Market
Exhibit 226. Neurodegenerative Diseases Biomarkers - Rest of World Market Estimations
and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$
Exhibit 227. Neurodegenerative Diseases Biomarkers - Rest of World Market Shares
(2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical
3.11.3.C.5 (I) Israeli Neurodegenerative Diseases Biomarkers Market
3.11.3.C.5 (II) South African Neurodegenerative Diseases Biomarkers Market
3.11.3.C.5 (III) Brazilian Neurodegenerative Diseases Biomarkers Market
Exhibit 228. List of Rest of World Neurodegenerative Diseases Biomarkers Companies
3.11.3.D OTHER NEUROLOGICAL DISORDERS
3.11.3.D.1 Global Other Neurological Disorder Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 229. Other Neurological Disorder Biomarkers - Global Market Estimations and
Exhibit 230. Other Neurological Disorder Biomarkers - Global Market Shares (2010, 2015
3.11.3.D.2 North American Other Neurological Disorder Biomarkers Market
Exhibit 231. Other Neurological Disorder Biomarkers North American Market
Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical
Exhibit 232. Other Neurological Disorder Biomarkers - North American Market Shares
3.11.3.D.3 European Other Neurological Disorder Biomarkers Market
Exhibit 233. Other Neurological Disorder Biomarkers European Market Estimations and
Included)
Exhibit 234. Other Neurological Disorder Biomarkers - European Market Shares (2010,
3.11.3.D.4 Asia-Pacific Other Neurological Disorder Biomarkers Market
Exhibit 235. Other Neurological Disorder Biomarkers - Asia-Pacific Market Estimations
Exhibit 236. Other Neurological Disorder Biomarkers - Asia-Pacific Market Shares (2010,
3.11.3.D.5 Rest of World Other Neurological Disorder Biomarkers Market
Exhibit 237. Other Neurological Disorder Biomarkers - Rest of World Market Estimations
Exhibit 238. Other Neurological Disorder Biomarkers - Rest of World Market Shares
3.11.4 INFECTIOUS DISEASES
3.11.4.1 Global Infectious Diseases Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 239. Biomarkers for Infectious Diseases- Global Market Estimations and
Predictions (2005-2020) in US$ Million for GIT, Respiratory Tract infections and Other
Exhibit 240. Biomarkers for Infectious Diseases- Global Market Shares (2010, 2015 &
2020) for GIT, Respiratory Tract infections and Other (Graphical Representation Included)
Exhibit 241. Biomarkers for Infectious Diseases - Global Market Estimations and
Exhibit 242. Biomarkers for Infectious Diseases - Global Market Shares (2010, 2015 &
3.11.4.2 North American Infectious Diseases Biomarkers Market
Exhibit 243. Biomarkers for Infectious Diseases - North American Market Estimations
Exhibit 244. Biomarkers for Infectious Diseases - North American Market Shares (2010,
3.11.4.2 (I) United States Infectious Diseases Biomarkers Market
3.11.4.2 (II) Canadian Infectious Diseases Biomarkers Market
Exhibit 245. List of North American Infectious Diseases Biomarkers Companies
3.11.4.3 European Infectious Diseases Biomarkers Market
Exhibit 246. Biomarkers for Infectious Diseases - European Market Estimations and
Included)
Exhibit 247. Biomarkers for Infectious Diseases - European Market Shares (2010, 2015 &
Rest of Europe (Graphical Representation Included)
3.11.4.3 (I) German Infectious Diseases Biomarkers Market
3.11.4.3 (II) United Kingdom Infectious Diseases Biomarkers Market
3.11.4.3 (III) Italian Infectious Diseases Biomarkers Market
3.11.4.3 (IV) French Infectious Diseases Biomarkers Market
3.11.4.3 (V) Spanish Infectious Diseases Biomarkers Market
3.11.4.3 (VI) Swiss Infectious Diseases Biomarkers Market
3.11.4.3 (VII) Belgian Infectious Diseases Biomarkers Market
3.11.4.3 (VIII) Swedish Infectious Diseases Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.4.3 (IX) Russian Infectious Diseases Biomarkers Market

Exhibit 248. List of European Infectious Diseases Biomarkers Companies
3.11.4.4 Asia-Pacific Infectious Diseases Biomarkers Market
Exhibit 249. Biomarkers for Infectious Diseases - Asia-Pacific Market Estimations and
Exhibit 250. Biomarkers for Infectious Diseases - Asia-Pacific Market Shares (2010, 2015
3.11.4.4 (I) Japanese Infectious Diseases Biomarkers Market
3.11.4.4 (II) Chinese Infectious Diseases Biomarkers Market
3.11.4.4 (III) Indian Infectious Diseases Biomarkers Market
3.11.4.4 (IV) Australian Infectious Diseases Biomarkers Market
3.11.4.4 (V) South Korean Infectious Diseases Biomarkers Market
Exhibit 251. List of Asia-Pacific Infectious Diseases Biomarkers Companies
3.11.4.5 Rest of World Infectious Diseases Biomarkers Market
Exhibit 252. Biomarkers for Infectious Diseases - Rest of World Market Estimations and
Exhibit 253. Biomarkers for Infectious Diseases - Rest of World Market Shares (2010,
3.11.4.5 (I) Israeli Infectious Diseases Biomarkers Market
3.11.4.5 (II) South African Infectious Diseases Biomarkers Market
3.11.4.5 (III) Brazilian Infectious Diseases Biomarkers Market
Exhibit 254. List of Rest of World Infectious Diseases Biomarkers Companies
3.11.4.A GASTROINTESTINAL TRACT INFECTIONS (GIT)
3.11.4.A.1 Global Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 255. Gastrointestinal Tract Infection (GIT) Biomarkers - Global Market
Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, AsiaPacific and Rest of World (Graphical Representation Included)
Exhibit 256. Gastrointestinal Tract Infection (GIT) Biomarkers - Global Market Shares
(2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World
3.11.4.A.2 North American Gastrointestinal Tract Infection (GIT) Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 257. Gastrointestinal Tract Infection (GIT) Biomarkers North American Market
Exhibit 258. Gastrointestinal Tract Infection (GIT) Biomarkers - North American Market
Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included)
3.11.4.A.2 (I) United States Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.2 (II) Canadian Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 259. List of North American Gastrointestinal Tract Infection (GIT) Biomarkers
Companies
3.11.4.A.3 European Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 260. Gastrointestinal Tract Infection (GIT) Biomarkers European Market
Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France,
Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical
Exhibit 261. Gastrointestinal Tract Infection (GIT) Biomarkers - European Market Shares
(2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium,
Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.11.4.A.3 (I) German Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (II) United Kingdom Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (III) Italian Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (IV) French Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (V) Spanish Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (VI) Swiss Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (VII) Belgian Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (VIII) Swedish Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.3 (IX) Russian Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 262. List of European Gastrointestinal Tract Infection (GIT) Biomarkers
Companies
3.11.4.A.4 Asia-Pacific Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 263. Gastrointestinal Tract Infection (GIT) Biomarkers - Asia-Pacific Market
Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia,
South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 264. Gastrointestinal Tract Infection (GIT) Biomarkers - Asia-Pacific Market
Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included)
3.11.4.A.4 (I) Japanese Gastrointestinal Tract Infection (GIT) Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.4.A.4 (II) Chinese Gastrointestinal Tract Infection (GIT) Biomarkers Market

3.11.4.A.4 (III) Indian Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.4 (IV) Australian Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.4 (V) South Korean Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 265. List of Asia-Pacific Gastrointestinal Tract Infection (GIT) Biomarkers
Companies
3.11.4.A.5 Rest of World Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 266. Gastrointestinal Tract Infection (GIT) Biomarkers - Rest of World Market
Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other
Countries in US$ Million (Graphical Representation Included)
Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries
3.11.4.A.5 (I) Israeli Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.5 (II) South African Gastrointestinal Tract Infection (GIT) Biomarkers Market
3.11.4.A.5 (III) Brazilian Gastrointestinal Tract Infection (GIT) Biomarkers Market
Exhibit 268. List of Rest of World Gastrointestinal Tract Infection (GIT) Biomarkers
Companies
3.11.4.B RESPIRATORY TRACT INFECTIONS
3.11.4.B.1 Global Respiratory Tract Infection Biomarkers Market
Exhibit 269. Respiratory Tract Infection Biomarkers - Global Market Estimations and
Exhibit 270. Respiratory Tract Infection Biomarkers - Global Market Shares (2010, 2015
3.11.4.B.2 North American Respiratory Tract Infection Biomarkers Market
List Of Figures
Exhibit 271. Respiratory Tract Infection Biomarkers North American Market Estimations
Exhibit 272. Respiratory Tract Infection Biomarkers - North American Market Shares
3.11.4.B.2 (I) United States Respiratory Tract Infection Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.4.B.2 (II) Canadian Respiratory Tract Infection Biomarkers Market

Exhibit 273. List of North American Respiratory Tract Infection Biomarkers Companies
3.11.4.B.3 European Respiratory Tract Infection Biomarkers Market
Exhibit 274. Respiratory Tract Infection Biomarkers European Market Estimations and
Included)
Exhibit 275. Respiratory Tract Infection Biomarkers - European Market Shares (2010,
3.11.4.B.3 (I) German Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (II) United Kingdom Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (III) Italian Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (IV) French Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (V) Spanish Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (VI) Swiss Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (VII) Belgian Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (VIII) Swedish Respiratory Tract Infection Biomarkers Market
3.11.4.B.3 (IX) Russian Respiratory Tract Infection Biomarkers Market
Exhibit 276. List of European Respiratory Tract Infection Biomarkers Companies
3.11.4.B.4 Asia-Pacific Respiratory Tract Infection Biomarkers Market
Exhibit 277. Respiratory Tract Infection Biomarkers - Asia-Pacific Market Estimations and
Exhibit 278. Respiratory Tract Infection Biomarkers - Asia-Pacific Market Shares (2010,
3.11.4.B.4 (I) Japanese Respiratory Tract Infection Biomarkers Market
3.11.4.B.4 (II) Chinese Respiratory Tract Infection Biomarkers Market
3.11.4.B.4 (III) Indian Respiratory Tract Infection Biomarkers Market
3.11.4.B.4 (IV) Australian Respiratory Tract Infection Biomarkers Market
3.11.4.B.4 (V) South Korean Respiratory Tract Infection Biomarkers Market
Exhibit 279. List of Asia-Pacific Respiratory Tract Infection Biomarkers Companies
3.11.4.B.5 Rest of World Respiratory Tract Infection Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 280. Respiratory Tract Infection Biomarkers - Rest of World Market Estimations
3.11.4.B.5 (I) Israeli Respiratory Tract Infection Biomarkers Market
3.11.4.B.5 (II) South African Respiratory Tract Infection Biomarkers Market
3.11.4.B.5 (III) Brazilian Respiratory Tract Infection Biomarkers Market
Exhibit 282. List of Rest of World Respiratory Tract Infection Biomarkers Companies
3.11.4.C OTHER INFECTIOUS DISEASES
3.11.4.C.1 Global Other Infectious Disease Biomarkers Market
Exhibit 283. Other Infectious Disease Biomarkers - Global Market Estimations and
Exhibit 284. Other Infectious Disease Biomarkers - Global Market Shares (2010, 2015 &
3.11.4.C.2 North American Other Infectious Disease Biomarkers Market
Exhibit 285. Other Infectious Disease Biomarkers North American Market Estimations
Exhibit 286. Other Infectious Disease Biomarkers - North American Market Shares (2010,
3.11.4.C.3 European Other Infectious Disease Biomarkers Market
Exhibit 287. Other Infectious Disease Biomarkers European Market Estimations and
Included)
Exhibit 288. Other Infectious Disease Biomarkers - European Market Shares (2010, 2015
& 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia
and Rest of Europe(Graphical Representation Included)
3.11.4.C.4 Asia-Pacific Other Infectious Disease Biomarkers Market
Exhibit 289. Other Infectious Disease Biomarkers - Asia-Pacific Market Estimations and

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 290. Other Infectious Disease Biomarkers - Asia-Pacific Market Shares (2010,
3.11.4.C.5 Rest of World Other Infectious Disease Biomarkers Market
Exhibit 291. Other Infectious Disease Biomarkers - Rest of World Market Estimations and
Exhibit 292. Other Infectious Disease Biomarkers - Rest of World Market Shares (2010,
3.11.5 GENETIC DISORDERS
3.11.5.1 Global Genetic Disorders Biomarkers Market
Exhibit 293. Biomarkers for Genetic Disorders - Global Market Estimations and
Exhibit 294. Biomarkers for Genetic Disorders - Global Market Shares (2010, 2015 &
3.11.5.2 North American Genetic Disorders Biomarkers Market
Exhibit 295. Biomarkers for Genetic Disorders - North American Market Estimations and
Included)
Exhibit 296. Biomarkers for Genetic Disorders - North American Market Shares (2010,
3.11.5.2 (I) United States Genetic Disorders Biomarkers Market
3.11.5.2 (II) Canadian Genetic Disorders Biomarkers Market
Exhibit 297. List of North American Genetic Disorders Biomarkers Companies
3.11.5.3 European Genetic Disorders Biomarkers Market
Exhibit 298. Biomarkers for Genetic Disorders - European Market Estimations and
Included)
Exhibit 299. Biomarkers for Genetic Disorders - European Market Shares (2010, 2015 &
Rest of Europe (Graphical Representation Included)
3.11.5.3 (I) German Genetic Disorders Biomarkers Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.11.5.3 (II) United Kingdom Genetic Disorders Biomarkers Market

3.11.5.3 (III) Italian Genetic Disorders Biomarkers Market
3.11.5.3 (IV) French Genetic Disorders Biomarkers Market
3.11.5.3 (V) Spanish Genetic Disorders Biomarkers Market
3.11.5.3 (VI) Swiss Genetic Disorders Biomarkers Market
3.11.5.3 (VII) Belgian Genetic Disorders Biomarkers Market
3.11.5.3 (VIII) Swedish Genetic Disorders Biomarkers Market
3.11.5.3 (IX) Russian Genetic Disorders Biomarkers Market
Exhibit 300. List of European Genetic Disorders Biomarkers Companies
3.11.5.4 Asia-Pacific Genetic Disorders Biomarkers Market
Exhibit 301. Biomarkers for Genetic Disorders - Asia-Pacific Market Estimations and
Exhibit 302. Biomarkers for Genetic Disorders - Asia-Pacific Market Shares (2010, 2015
3.11.5.4 (I) Japanese Genetic Disorders Biomarkers Market
3.11.5.4 (II) Chinese Genetic Disorders Biomarkers Market
3.11.5.4 (III) Indian Genetic Disorders Biomarkers Market
3.11.5.4 (IV) Australian Genetic Disorders Biomarkers Market
3.11.5.4 (V) South Korean Genetic Disorders Biomarkers Market
Exhibit 303. List of Asia-Pacific Genetic Disorders Biomarkers Companies
3.11.5.5 Rest of World Genetic Disorders Biomarkers Market
Exhibit 304. Biomarkers for Genetic Disorders - Rest of World Market Estimations and
Exhibit 305. Biomarkers for Genetic Disorders - Rest of World Market Shares (2010, 2015
& 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation
Included)
3.11.5.5 (I) Israeli Genetic Disorders Biomarkers Market
3.11.5.5 (II) South African Genetic Disorders Biomarkers Market
3.11.5.5 (III) Brazilian Genetic Disorders Biomarkers Market
Exhibit 306. List of Rest of World Genetic Disorders Biomarkers Companies
3.11.6 OTHER THREAPUTIC AREAS
3.11.6.1 Global Biomarkers Market for Other Therapeutic Areas

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 307. Biomarkers for Other Therapeutic Areas - Global Market Estimations and
Exhibit 308. Biomarkers for Other Therapeutic Areas - Global Market Shares (2010, 2015
3.11.6.2 North American Biomarkers Market for Other Therapeutic Areas
Exhibit 309. Biomarkers for Other Therapeutic Areas - North American Market
Exhibit 310. Biomarkers for Other Therapeutic Areas - North American Market Shares
3.11.6.3 European Biomarkers Market for Other Therapeutic Areas
Exhibit 311. Biomarkers for Other Therapeutic Areas - European Market Estimations and
Predictions (2005-2020)
in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden,
Exhibit 312. Biomarkers for Other Therapeutic Areas - European Market Shares (2010,
3.11.6.4 Asia-Pacific Biomarkers Market for Other Therapeutic Areas
Exhibit 313. Biomarkers for Other Therapeutic Areas - Asia-Pacific Market Estimations
Exhibit 314. Biomarkers for Other Therapeutic Areas - Asia-Pacific Market Shares (2010,
Exhibit 315. Biomarkers for Other Therapeutic Areas - Rest of World Market Estimations
Million in US$ Million (Graphical Representation Included)
Exhibit 316. Biomarkers for Other Therapeutic Areas - Rest of World Market Shares
3.12 Biomarker Identification Technology Analysis by Geographic Region

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 317. Biomarkers by Identification Technology - Global Market Estimations and

Predictions (2005-2020) in US$ Million for Imaging, Genomics, Proteomics,
Metabolomics, Gene Expression & Other (Graphical Representation Included)
Exhibit 318. Biomarkers - Global Market Shares (2010, 2015 & 2020) for Imaging,
Genomics, Proteomics, Metabolomics, Gene Expression & Other (Graphical
3.12.1 IMAGING
3.12.1.1 Global Biomarkers Imaging Technologies Market
Exhibit 319. Imaging Technologies for Biomarker Identification - Global Market
Exhibit 320. Imaging Technologies for Biomarker Identification - Global Market Shares
3.12.1.2 North American Biomarkers Imaging Technologies Market
Exhibit 321. Imaging Technologies for Biomarker Identification North American Market
Exhibit 322. Imaging Technologies for Biomarker Identification - North American Market
3.12.1.2 (I) United States Biomarkers Imaging Technologies Market
3.12.1.2 (II) Canadian Biomarkers Imaging Technologies Market
Exhibit 323. List of North American Biomarkers Imaging Technologies Companies
3.12.1.3 European Biomarkers Imaging Technologies Market
Exhibit 324. Imaging Technologies for Biomarker Identification European Market
Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe
Exhibit 325. Imaging Technologies for Biomarker Identification - European Market Shares
3.12.1.3 (I) German Biomarkers Imaging Technologies Market
3.12.1.3 (II) United Kingdom Imaging Technologies Market
3.12.1.3 (III) Italian Biomarkers Imaging Technologies Market
3.12.1.3 (IV) French Biomarkers Imaging Technologies Market
3.12.1.3 (V) Spanish Biomarkers Imaging Technologies Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.12.1.3 (VI) Swiss Biomarkers Imaging Technologies Market

3.12.1.3 (VII) Belgian Biomarkers Imaging Technologies Market
3.12.1.3 (VIII) Swedish Biomarkers Imaging Technologies Market
3.12.1.3 (IX) Russian Biomarkers Imaging Technologies Market
Exhibit 326. List of European Biomarkers Imaging Technologies Companies
3.12.1.4 Asia-Pacific Biomarkers Imaging Technologies Market
Exhibit 327. Imaging Technologies for Biomarker Identification - Asia-Pacific Market
Exhibit 328. Imaging Technologies for Biomarker Identification - Asia-Pacific Market
3.12.1.4 (I) Japanese Biomarkers Imaging Technologies Market
3.12.1.4 (II) Chinese Biomarkers Imaging Technologies Market
3.12.1.4 (III) Indian Biomarkers Imaging Technologies Market
3.12.1.4 (IV) Australian Biomarkers Imaging Technologies Market
3.12.1.4 (V) South Korean Biomarkers Imaging Technologies Market
Exhibit 329. List of Asia-Pacific Biomarkers Imaging Technologies Companies
3.12.1.5 Rest of World Biomarkers Imaging Technologies Market
Exhibit 330. Imaging Technologies for Biomarker Identification - Rest of World Market
Exhibit 331. Imaging Technologies for Biomarker Identification - Rest of World Market
3.12.1.5 (I) Israeli Biomarkers Imaging Technologies Market
3.12.1.5 (II) South African Biomarkers Imaging Technologies Market
3.12.1.5 (III) Brazilian Biomarkers Imaging Technologies Market
Exhibit 332. List of Rest of World Biomarkers Imaging Technologies Companies
3.12.2 GENOMICS
3.12.2.1 Global Biomarkers Genomic Technologies Market
Exhibit 333. Genomic Technologies for Biomarker Identification - Global Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 334. Genomic Technologies for Biomarker Identification - Global Market Shares
3.12.2.2 North American Biomarkers Genomic Technologies Market
Exhibit 335. Genomic Technologies for Biomarker Identification North American Market
Exhibit 336. Genomic Technologies for Biomarker Identification - North American Market
3.12 .2.2 (I) United States Biomarkers Genomic Technologies Market
3.12.2.2 (II) Canadian Biomarkers Genomic Technologies Market
Exhibit 337. List of North American Biomarkers Genomic Technologies Companies
3.12.2.3 European Biomarkers Genomic Technologies Market
Exhibit 338. Genomic Technologies for Biomarker Identification European Market
Exhibit 339. Genomic Technologies for Biomarker Identification - European Market
Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium,
3.12.2.3 (I) German Biomarkers Genomic Technologies Market
3.12.2.3 (II) United Kingdom Genomic Technologies Market
3.12.2.3 (III) Italian Biomarkers Genomic Technologies Market
3.12.2.3 (IV) French Biomarkers Genomic Technologies Market
3.12 .2.3 (V) Spanish Biomarkers Genomic Technologies Market
3.12.2.3 (VI) Swiss Biomarkers Genomic Technologies Market
3.12.2.3 (VII) Belgian Biomarkers Genomic Technologies Market
3.12.2.3 (VIII) Swedish Biomarkers Genomic Technologies Market
3.12.2.3 (IX) Russian Biomarkers Genomic Technologies Market
Exhibit 340. List of European Biomarkers Genomic Technologies Companies
3.12.2.4 Asia-Pacific Biomarkers Genomic Technologies Market
Exhibit 341. Genomic Technologies for Biomarker Identification - Asia-Pacific Market
South Korea and Asia-Pacific (Graphical Representation
Included)

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 342. Genomic Technologies for Biomarker Identification - Asia-Pacific Market

3.12.2.4 (I) Japanese Biomarkers Genomic Technologies Market
3.12.2.4 (II) Chinese Biomarkers Genomic Technologies Market
3.12.2.4 (III) Indian Biomarkers Genomic Technologies Market
3.12.2.4 (IV) Australian Biomarkers Genomic Technologies Market
3.12.2.4 (V) South Korean Biomarkers Genomic Technologies Market
Exhibit 343. List of Asia-Pacific Biomarkers Genomic Technologies Companies
3.12.2.5 Rest of World Biomarkers Genomic Technologies Market
Exhibit 344. Genomic Technologies for Biomarker Identification - Rest of World Market
Exhibit 345. Genomic Technologies for Biomarker Identification - Rest of World Market
3.12.2.5 (I) Israeli Biomarkers Genomic Technologies Market
3.12.2.5 (II) South African Biomarkers Genomic Technologies Market
3.12.2.5 (III) Brazilian Biomarkers Genomic Technologies Market
Exhibit 346. List of Rest of World Biomarkers Genomic Technologies Companies
3.12.3 PROTEOMICS
3.12.3.1 Global Biomarkers Proteomic Technologies Market
Exhibit 347. Proteomic Technologies for Biomarker Identification - Global Market
Exhibit 348. Proteomic Technologies for Biomarker Identification - Global Market Shares
3.12.3.2 North American Biomarkers Proteomic Technologies Market
Exhibit 349. Proteomic Technologies for Biomarker Identification North American
Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada
Exhibit 350. Proteomic Technologies for Biomarker Identification - North American
Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation
Included)
3.12.3.2 (I) United States Biomarkers Proteomic Technologies Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.12.3.2 (II) Canadian Biomarkers Proteomic Technologies Market

Exhibit 351. List of North American Biomarkers Proteomic Technologies Companies
3.12.3.3 European Biomarkers Proteomic Technologies Market
Exhibit 352. Proteomic Technologies for Biomarker Identification European Market
Exhibit 353. Proteomic Technologies for Biomarker Identification - European Market
3.12.3.3 (I) German Biomarkers Proteomic Technologies Market
3.12 .3.3 (II) United Kingdom Proteomic Technologies Market
3.12.3.3 (III) Italian Biomarkers Proteomic Technologies Market
3.12.3.3 (IV) French Biomarkers Proteomic Technologies Market
3.12.3.3 (I) Spanish Biomarkers Proteomic Technologies Market
3.12.3.3 (VI) Swiss Biomarkers Proteomic Technologies Market
3.12.3.3 (VII) Belgian Biomarkers Proteomic Technologies Market
3.12.3.3 (VIII) Swedish Biomarkers Proteomic Technologies Market
3.12.3.3 (IX) Russian Biomarkers Proteomic Technologies Market
Exhibit 354. List of European Biomarkers Proteomic Technologies Companies
3.12.3.4 Asia-Pacific Biomarkers Proteomic Technologies Market
Exhibit 355. Proteomic Technologies for Biomarker Identification - Asia-Pacific Market
Exhibit 356. Proteomic Technologies for Biomarker Identification - Asia-Pacific Market
3.12.3.4 (I) Japanese Biomarkers Proteomic Technologies Market
3.12.3.4 (II) Chinese Biomarkers Proteomic Technologies Market
3.12.3.4 (III) Indian Biomarkers Proteomic Technologies Market
3.12.3.4 (IV) Australian Biomarkers Proteomic Technologies Market
3.12.3.4 (V) South Korean Biomarkers Proteomic Technologies Market
Exhibit 357. List of Asia-Pacific Biomarkers Proteomic Technologies Companies
3.12.3.5 Rest of World Biomarkers Proteomic Technologies Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 358. Proteomic Technologies for Biomarker Identification - Rest of World Market
Exhibit 359. Proteomic Technologies for Biomarker Identification - Rest of World Market
3.12.3.5 (I) Israeli Biomarkers Proteomic Technologies Market
3.12.3.5 (II) South African Biomarkers Proteomic Technologies Market
3.12.3.5 (III) Brazilian Biomarkers Proteomic Technologies Market
Exhibit 360. List of Rest of World Biomarkers Proteomic Technologies Companies
3.12.4 METABOLOMICS
3.12.4.1 Global Biomarkers Metabolomics Technologies Market
Exhibit 361. Metabolomics Technologies for Biomarker Identification - Global Market
Exhibit 362. Metabolomics Technologies for Biomarker Identification - Global Market
Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World
3.12.4.2 North American Biomarkers Metabolomics Technologies Market
Exhibit 363. Metabolomics Technologies for Biomarker Identification North American
Exhibit 364. Metabolomics Technologies for Biomarker Identification - North American
Included)
3.12.4.2 (I) United States Biomarkers Metabolomics Technologies Market
3.12.4.2 (II) Canadian Biomarkers Metabolomics Technologies Market
Exhibit 365. List of North American Biomarkers Metabolomics Technologies Companies
3.12.4.3 European Biomarkers Metabolomics Technologies Market
Exhibit 366. Metabolomics Technologies for Biomarker Identification European Market
Exhibit 367. Metabolomics Technologies for Biomarker Identification - European Market

Tel No- 91 2241236650 / +91 - 998 729 5242
3.12.4.3 (I) German Biomarkers Metabolomics Technologies Market

3.12.4.3 (II) United Kingdom Metabolomics Technologies Market
3.12.4.3 (III) Italian Biomarkers Metabolomics Technologies Market
3.12.4.3 (IV) French Biomarkers Metabolomics Technologies Market
3.12.4.3 (V) Spanish Biomarkers Metabolomics Technologies Market
3.12.4.3 (VI) Swiss Biomarkers Metabolomics Technologies Market
3.12.4.3 (VII) Belgian Biomarkers Metabolomics Technologies Market
3.12.4.3 (VIII) Swedish Biomarkers Metabolomics Technologies Market
3.12.4.3 (IX) Russian Biomarkers Metabolomics Technologies Market
Exhibit 368. List of European Biomarkers Metabolomics Technologies Companies
3.12.4.4 Asia-Pacific Biomarkers Metabolomics Technologies Market
Exhibit 369. Metabolomics Technologies for Biomarker Identification - Asia-Pacific
Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India,
Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 370. Metabolomics Technologies for Biomarker Identification - Asia-Pacific
Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and
Asia-Pacific (Graphical Representation Included)
3.12.4.4 (I) Japanese Biomarkers Metabolomics Technologies Market
3.12.4.4 (II) Chinese Biomarkers Metabolomics Technologies Market
3.12.4.4 (III) Indian Biomarkers Metabolomics Technologies Market
3.12.4.4 (IV) Australian Biomarkers Metabolomics Technologies Market
3.12.4.4 (V) South Korean Biomarkers Metabolomics Technologies Market
Exhibit 371. List of Asia-Pacific Biomarkers Metabolomics Technologies Companies
3.12.4.5 Rest of World Biomarkers Metabolomics Technologies Market
Exhibit 372. Metabolomics Technologies for Biomarker Identification - Rest of World
Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other
Exhibit 373. Metabolomics Technologies for Biomarker Identification - Rest of World
Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries
3.12.4.5 (I) Israeli Biomarkers Metabolomics Technologies Market
3.12.4.5 (II) South African Biomarkers Metabolomics Technologies Market
3.12.4.5 (III) Brazilian Biomarkers Metabolomics Technologies Market
Exhibit 374. List of Rest of World Biomarkers Metabolomics Technologies Companies
3.12.5.GENE EXPRESSION
3.12.5.1Global Biomarkers Gene Expression Technologies Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 375. Gene Expression Technologies for Biomarker Identification - Global Market
Exhibit 376. Gene Expression Technologies for Biomarker Identification - Global Market
Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World
3.12.5.2 North American Biomarkers Gene Expression Technologies Market
Exhibit 377. Gene Expression Technologies for Biomarker Identification North American
Exhibit 378. Gene Expression Technologies for Biomarker Identification - North American
Included)
3.12.5.2 (I) United States Biomarkers Gene Expression Technologies Market
3.12.5.2 (II) Canadian Biomarkers Gene Expression Technologies Market
Exhibit 379. List of North American Biomarkers Gene Expression Technologies
Companies
3.12.5.3 European Biomarkers Gene Expression Technologies Market
Exhibit 380. Gene Expression Technologies for Biomarker Identification European
Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy,
France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical
Exhibit 381. Gene Expression Technologies for Biomarker Identification - European
Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland,
Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)
3.12.5.3 (I) German Biomarkers Gene Expression Technologies Market
3.12.5.3 (II) United Kingdom Gene Expression Technologies Market
3.12.5.3 (III) Italian Biomarkers Gene Expression Technologies Market
3.12.5.3 (IV) French Biomarkers Gene Expression Technologies Market
3.12.5.3 (V) Spanish Biomarkers Gene Expression Technologies Market
3.12.5.3 (VI) Swiss Biomarkers Gene Expression Technologies Market
3.12.5.3 (VII) Belgian Biomarkers Gene Expression Technologies Market
3.12.5.3 (VIII) Swedish Biomarkers Gene Expression Technologies Market
3.12.5.3 (IX) Russian Biomarkers Gene Expression Technologies Market
Exhibit 382. List of European Biomarkers Gene Expression Technologies Companies
3.12.5.4 Asia-Pacific Biomarkers Gene Expression Technologies Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 383. Gene Expression Technologies for Biomarker Identification - Asia-Pacific

Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India,
Australia, South Korea and Asia-Pacific (Graphical Representation Included)
Exhibit 384. Gene Expression Technologies for Biomarker Identification - Asia-Pacific
Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and
Asia-Pacific (Graphical Representation Included)
3.12.5.4 (I) Japanese Biomarkers Gene Expression Technologies Market
3.12.5.4 (II) Chinese Biomarkers Gene Expression Technologies Market
3.12.5.4 (III) Indian Biomarkers Gene Expression Technologies Market
3.12.5.4 (IV) Australian Biomarkers Gene Expression Technologies Market
3.12.5.4 (V) South Korean Biomarkers Gene Expression Technologies Market
Exhibit 385. List of Asia-Pacific Biomarkers Gene Expression Technologies Companies
3.12.5.5 Rest of World Biomarkers Gene Expression Technologies Market
Exhibit 386. Gene Expression Technologies for Biomarker Identification - Rest of World
Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other
Exhibit 387. Gene Expression Technologies for Biomarker Identification - Rest of World
Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries
3.12.5.5 (I) Israeli Biomarkers Gene Expression Technologies Market
3.12.5.5 (II) South African Biomarkers Gene Expression Technologies Market
3.12.5.5 (III) Brazilian Biomarkers Gene Expression Technologies Market
Exhibit 388. List of Rest of World Biomarkers Gene Expression Technologies Companies
3.12.6 OTHER IDENTIFICATION TECHNOLOGIES
3.12.6.1 Global Other Biomarkers Identification Technologies Market
Exhibit 389. Other Biomarkers Identification Technologies - Global Market Estimations
and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and
Rest of World (Graphical Representation Included)
Exhibit 390. Other Biomarkers Identification Technologies - Global Market Shares (2010,
2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical
3.12.6.2 North American Other Biomarkers Identification Technologies Market
Exhibit 391. Other Biomarkers Identification Technologies North American Market

Tel No- 91 2241236650 / +91 - 998 729 5242
Exhibit 392. Other Biomarkers Identification Technologies - North American Market

3.12.6.3 European Other Biomarkers Identification Technologies Market
Exhibit 393. Other Biomarkers Identification Technologies European Market Estimations
and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain,
Included)
Exhibit 394. Other Biomarkers Identification Technologies - European Market Shares
3.12.6.4 Asia-Pacific Other Biomarkers Identification Technologies Market
Exhibit 395. Other Biomarkers Identification Technologies - Asia-Pacific Market
Exhibit 396. Other Biomarkers Identification Technologies - Asia-Pacific Market Shares
(2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific
3.12.6.5 Rest of World Other Biomarkers Identification Technologies Market
Exhibit 397. Other Biomarkers Identification Technologies - Rest of World Market
Exhibit 398. Other Biomarkers Identification Technologies - Rest of World Market Shares
3.13 Biomarkers - Market Outlook
4. PRODUCT/TECHNOLOGY RESEARCH
4.1. Introduction
Biomarker Groups
Biomarkers of Exposure
Therapeutic Biomarkers
Laboratory Process of Biomarkers Development
Application of Biomarkers
Medical Sector
Non-Medical Sector
Geochemistry
Astrobiology

Tel No- 91 2241236650 / +91 - 998 729 5242
Classification of Biomarkers
Classification based on applications
Categorization of Biomarkers
DNA Biomarkers
RNA Biomarkers
Gene Biomarkers
Metabolic Biomarkers
Cell Biomarkers
Protein Biomarkers
Biomarkers and Molecular Diagnostics
Systems Biology
Aim of Systems Biology
Omics Technologies Based Systems Biology
4.2 Various Diseases - Role of Biomarkers
Therapeutic Areas
Exhibit 399. List of FDA Approved and Potential Serum Biomarkers for Various Diseases
Oncology
Cancer Biomarkers
Application of Biomarkers in Cancer Treatment
Exhibit 400. List of Cancer Biomarkers - Established and Specialized Biomarkers
Established Cancer Biomarkers
Specialized Cancer Biomarkers
Lung Cancer
Lung Cancer and Biomarkers
Features of Biomarker for Lung Cancer
Breast Cancer
Breast Cancer Biomarkers
Exhibit 401. List of Breast Cancer Biomarkers at Different Disease Stages
Ovarian Cancer
Ovarian Cancer Biomarkers
Exhibit 402. List of Ovarian Cancer Biomarkers at Different Disease Stages
Mass Spectrometry - An Emerging Tool for Cancer Biomarker Identification
Prostate Cancer
Serum Biomarkers
Prostate-Specific Antigen
Other Serum Biomarkers

Tel No- 91 2241236650 / +91 - 998 729 5242
Cardiology
Cardiac Biomarkers - An Overview
Renal Insufficiency-Risk of Cardiovascular Disease
Exhibit 403. List of Biomarkers for Various Renal Insufficiency Related Specific Diseases
Established Cardiovascular Biomarkers
Specialized Cardiovascular Biomarkers
Exhibit 404. List of Established, Specialized and Emerging Biomarkers for Cardiovascular
Diseases
Congenital Heart Defects
Obesity and Overweight
Cardiac Rehabilitation
Exhibit 405. List of Established and Specialized Hematology Biomarkers to Asses Risk for
Heart Failure
Exhibit 406. List of Emerging Cell Signaling Biomarkers for Prognosis & Diagnosis of
Various
Diseases Myocardial Infarction
Exhibit 407. List of Biomarkers for Myocardial Infarction and Risk of Heart Failure
Biomarkers in Diabetes
Established Diabetes Biomarkers
Specialized Diabetes Biomarkers
Neurology
Neurodegenerative Disorders
Most Common Neurodegenerative Diseases
Alzheimers Disease
Diagnosis of Alzheimers Disease
Parkinsons Disease
Psychiatric Disorder
Brain Stroke
Stroke
Infectious Diseases
Exhibit 408. List of Infectious Diseases Biomarkers for Bacterial/Parasitic Exposure
Exhibit 409. List of Infectious Diseases Biomarkers for Viral Exposure
Established Biomarkers
Specialized Infectious Disease Biomarkers
Exhibit 410. List of Biomarkers for Gastro Intestinal Tract Infections
Role of Biomarkers in Malaria Treatment

Tel No- 91 2241236650 / +91 - 998 729 5242
Respiratory Infections
Tuberculosis
Biomarkers for Diagnosis of SARS Disease
Role of Biomarkers in HIV Diagnosis
Biomarkers for Chikungunya
Role of Biomarkers in Sepsis Diagnosis
Genetic Disorders
Other Therapeutic Area
Autoimmune Diseases
Biomarkers for Detection of Arthritis
Rheumatic Arthritis
Established Osteoarthritis Biomarkers
Biomarkers in Gynecology
Established Autoimmune Biomarkers
Specialized Autoimmune Biomarkers
Established Endocrine Biomarkers
Exhibit 411. List of Thyroid/Parathyroid Biomarkers
Exhibit 412. List of Biomarkers for Sex Hormones
Established Biomarkers
Specialized Biomarkers
Exhibit 413. List of Established Nutritional Biomarkers
Established Hematology Biomarkers
Specialized Hematology Biomarkers
Established Organ Systems Biomarkers
Exhibit 414. List of Liver Biomarkers
Gastrointestinal
Campylobacter Jejuni Antibody
Liver
Established Immune/Inflammation Biomarkers
Specialized Immune/Inflammation Biomarkers
Exhibit 415. List of Ageing Biomarkers and Their Effects on Human Body
4.3 Biomarker Identification Technologies
Imaging Technologies
Genomics
Proteomics
Metabolomics

Tel No- 91 2241236650 / +91 - 998 729 5242
Gene Expression
Other
4.4 Biomarkers in Drug Discovery/Development
Why is Pharma/Biotech Industry Keen on Biomarkers
Application and Benefits of Biomarkers in Drug Development
Verification of Biomarkers Applicability
Biomarkers Application in Clinical Drug Development
Biomarkers Effect on Discovery and Application of a Drug
Drug Safety and Role of Biomarkers
Exhibit 416. List of Isotope Biomarkers with Their Area of Application
4.5 Product Trends
Enhanced Treatment for Spondylarthritis with Innovative Biomarkers
A New Diagnostic Marker to Measure Efficiency of Cancer Drug
SINE RNA to Emerge as Biomarker for Tobacco Hazards
Kinetic Biomarker Enhances Drug Development
New Biomarkers to Detect Nephrotoxicity
Biomarkers in Combination with Pharmacogenomics
4.6 Biomarkers - Research Briefs
Early Biomarker of Insulin Resistance and Glucose Intolerance Identified in a Non-diabetic
Population
SNP as Molecular Biomarkers
Identification of Potential NAFLD Noninvasive Biomarkers
Blood Biomarker in Association with Inflammation
Cardiac Biomarker Indicates Fluid Overload in Dialysis Patients
Research Identifies Novel Biomarker for Non-Small Cell Lung Carcinomas (NSCLC)
Biomarkers May Offer Hope of New Osteoarthritis Test
Biomarkers Found to Diagnose Chagas Disease
BATTLE Identifies Potential Biomarkers
Biomarker for Multiple Sclerosis Discovered by Researchers
A Biomarker for the indication of lymphoma treatment
The progress of biomarkers in the war against lung cancer
Nanosensors to Determine Cancer Biomarkers in Blood
More..

Tel No- 91 2241236650 / +91 - 998 729 5242
5. CORPORATE DIRECTORY
6. PATENTS INFORMATION
Product Price :
License Type
Price
PDF
$ 4680
Global Licence
$ 9500
Related reports:
Global Anxiety Disorders Market 2015-2019
Global Breast Imaging Market 2015-2019
Global Cancer Biomarkers Market 2015-2019
Global Fluid Treatment Market 2015-2019
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT
Analysis Review
TTK Healthcare Limited (TTKHEALTH) - Financial and Strategic SWOT
Analysis Review
RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis
Review
DiagnoCure Inc. (CUR) - Financial and Strategic SWOT Analysis Review

Tel No- 91 2241236650 / +91 - 998 729 5242
NanoCarrier Co., Ltd. (4571) - Financial and Strategic SWOT Analysis Review
Healthcare and Medical Market Research
You can order this report by calling on +91 - 998 7295 242 or mail us your
contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is
one-stop-shop for all information related to market research for any sector of the industry.
Along with providing in-depth analysis though reports, JSB market research also provides
regular updates of the market though newsletters. Our reports are a well-researched work
of market researchers with an extensive knowledge and a good level of market experience.
To know more on BIOMARKERS
http://www.jsbmarketresearch.com/healthcare-medical/r-biomarkers-68420

Tel No- 91 2241236650 / +91 - 998 729 5242

Biomarkers: Released On 27 January 2015

Hochgeladen von

Dokumentinformationen

Originalbeschreibung:

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Biomarkers: Released On 27 January 2015

Hochgeladen von

Copyright:

Verfügbare Formate

BIOMARKERS

Released On 27th January 2015

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.6 Rest of World Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.1.3 (I) German Oncology Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Exhibit 54. List of North American Ovarian Cancer Biomarkers Companies

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.1. C.3 (VI) Swiss Breast Cancer Biomarkers Market

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.1. D.4 (I) Japanese Lung Cancer Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.2.4 (V) South Korean Cardiology Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.2.C.5 Rest of World Myocardial Infarction Biomarkers Market

Email ID- contact@jsbmarketresearch.com

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

Exhibit 178. Biomarkers in Neurology - European Market Estimations and Predictions

Email ID- contact@jsbmarketresearch.com

3.11.3.5 (I) Israeli Neurology Biomarkers Market

Email ID- contact@jsbmarketresearch.com

3.11.3.A.4 Asia-Pacific Stroke Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.3.C.3 (II) United Kingdom Neurodegenerative Diseases Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.4.3 (IX) Russian Infectious Diseases Biomarkers Market

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.4.A.4 (II) Chinese Gastrointestinal Tract Infection (GIT) Biomarkers Market

Email ID- contact@jsbmarketresearch.com

3.11.4.B.2 (II) Canadian Respiratory Tract Infection Biomarkers Market

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.11.5.3 (II) United Kingdom Genetic Disorders Biomarkers Market

Email ID- contact@jsbmarketresearch.com

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

Exhibit 317. Biomarkers by Identification Technology - Global Market Estimations and